Global $6.5 Billion Liquid Biopsy Market to 2026 - Increasing Focus of Manufacturers on Research & Development Through Collaborations to Bolster Growth

DUBLIN, Jan. 30, 2019 /PRNewswire/ --

The "Liquid Biopsy Market (by Circulating Biomarker, Product, Application, End User, Clinical Application, Cancer Types, Sample Type, Regional & Country Wise Analysis), Initiatives, Funding and 20 Company Profile - Global Forecast to 2026" company profile has been added to ResearchAndMarkets.com's offering.

The global liquid biopsy market is expected to reach nearly US$ 6.5 Billion by 2026

Liquid biopsy is a non-invasive technology that detects molecular biomarkers using liquid sample without the need for costly or invasive procedures.

The abilities of liquid biopsy like, easy and minimal invasiveness, early cancer diagnosis & detection, characterization of new lesions, drug & therapeutic target identifications for cancer treatment are some advantages of liquid biopsies, which improve the safety and efficiency of cancer therapy for patients.

The advantages of liquid biopsy over solid tumor biopsy, rising prevalence of cancer, increasing preference for non-invasive procedures, growing public and private funding to support research activities in the field of liquid biopsy and favorable government initiatives, are some of the factors expected to propel the growth of liquid biopsy market in the coming years.

Some of the key factors inhibiting the growth of liquid biopsy market includes, clinical utility challenges, lack of sensitivity and specificity of liquid biopsy tests and unclear reimbursement & regulation scenario.

Report Highlights

Global Liquid Biopsy Market & Forecast - by Circulating Biomarker

• Based on circulating biomarkers, the global liquid biopsy market is being dominated by Circulating Tumor Cells (CTCs).
• The circulating tumor DNA (ctDNA) is the second largest segment of the liquid biopsy market.
• The cell free DNA (cfDNA) is the third largest segment of the liquid biopsy market.
• The extracellular vesicles (EVs) segment is the fastest growing segment during the forecast period.

Global Liquid Biopsy Market & Forecast - by Product

• The global liquid biopsy market, by product, is being dominated by Kits and Consumables.
• The instruments segment is likely to witness highest growth in the global liquid biopsy market.
• The services segment captured least share of the liquid biopsy market.

Global Liquid Biopsy Market & Forecast - by Application

• The global liquid biopsy market, by application, is being dominated by oncology application.
• Lung cancer and breast cancer accounts for largest share of the liquid biopsy oncology market.
• The non-cancer application segment is expected to be the fastest-growing segment in the market during the forecast period.

Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application

• On the basis of clinical application, the therapy selection segment is expected to account for largest share of the liquid biopsy market throughout the forecasting period.
• Treatment monitoring captured second highest share of the liquid biopsy market in 2018, being followed by the early cancer screening application.
• Recurrence monitoring captured least share of the liquid biopsy market.

Global Liquid Biopsy Market & Forecast - by End User

• In 2018, Reference laboratories captured largest share of the global liquid biopsy market.
• Hospital and Physician laboratories occupied second highest share of the liquid biopsy market in 2018, being followed by Academic and Research Centers.

Global Liquid Biopsy Market & Forecast - by Sample Type

• Blood is the most widely used sample type and is expected to remain the largest market during the forecasting period as well.
• The urine sample segment is anticipated to witness noticeable growth throughout the forecasting period.

Liquid Biopsy Market & Forecast - Regional Analysis

• North America accounted for largest share of the global liquid biopsy market in 2018, followed by Asia Pacific.
• In North America, United States accounted for largest share of the liquid biopsy market.
• In Europe, Germany and France are the leading market for liquid biopsy.
• Asia pacific is likely to be the fastest growing market for liquid biopsy during the forecasting period.
• In Asia Pacific, Japan and China are the leading market for liquid biopsy.
• Latin America is the fourth largest market for liquid biopsy, being followed by Middle East & Africa.

Market Dynamics

Driving Factors

• Rising Applications of Liquid Biopsy Expected to Boost Liquid Biopsy Market
• Personalized Medicine to Spur Use of Liquid Biopsy Tests in Clinical Practice
• Rising Aging Population and Cancer Incidences to Drive Liquid Biopsy Market
• New Liquid Biopsy Product Launches to Fuel Market Revenues
• Increasing Focus of Manufacturers on Research & Development Through Collaborations To bolster Growth of Liquid Biopsy Market

Challenges

• Limitations in Third-Party Payer Coverage to Restrict Liquid Biopsy Market
• Liquid Biopsy Clinical Utility Challenges

Key Topics Covered:

1. Executive Summary

2. Global Liquid Biopsy Market & Forecast (2015 - 2026)

3. Global Liquid Biopsy Market Share & Forecast (2015 - 2026)
3.1 Global Liquid Biopsy Market Share & Forecast - by Circulating Biomarker
3.2 Global Liquid Biopsy Market Share & Forecast - by Product
3.3 Global Liquid Biopsy Market Share & Forecast - by Application
3.4 Global Liquid Biopsy Oncology Market Share & Forecast - by Clinical Application
3.5 Global Liquid Biopsy Oncology Market Share & Forecast - By Cancer Types
3.6 Global Liquid Biopsy Market Share & Forecast - by End User
3.7 Global Liquid Biopsy Market Share & Forecast - by Sample Type
3.8 Liquid Biopsy Market Share & Forecast - Regional Analysis
3.9 Liquid Biopsy Market Share & Forecast - Country Wise Analysis

4. Global Liquid Biopsy Market & Forecast - by Circulating Biomarker (2015 - 2026)
4.1 Global Liquid Biopsy - Circulating Tumor Cells (CTCs) Market & Forecast
4.2 Global Liquid Biopsy - Circulating Tumor DNA (ctDNA) Market & Forecast
4.3 Global Liquid Biopsy - Cell-Free DNA (cfDNA) Market & Forecast
4.4 Global Liquid Biopsy - Extracellular Vesicles (EVs) Market & Forecast
4.5 Global Liquid Biopsy - Other Circulating Biomarkers Market & Forecast

5. Global Liquid Biopsy Market & Forecast - by Product (2015 - 2026)
5.1 Global Liquid Biopsy - Kits and Consumables Market & Forecast
5.2 Global Liquid Biopsy - Instruments Market & Forecast
5.3 Global Liquid Biopsy - Services Market & Forecast

6. Global Liquid Biopsy Market & Forecast - by Application (2015 - 2026)
6.1 Global Liquid Biopsy - Oncology Application Market & Forecast
6.2 Global Liquid Biopsy Oncology Market & Forecast - By Cancer Types
6.2.1 Lung Cancer Liquid Biopsy Market & Forecast
6.2.2 Breast Cancer Liquid Biopsy Market & Forecast
6.2.3 Colorectal Cancer Liquid Biopsy Market & Forecast
6.2.4 Prostate Cancer Liquid Biopsy Market & Forecast
6.2.5 Gastrointestinal Cancer Liquid Biopsy Market & Forecast
6.2.6 Leukaemia Liquid Biopsy Market & Forecast
6.2.7 Others Liquid Biopsy Market & Forecast
6.3 Global Liquid Biopsy - Non-Cancer Application Market & Forecast

7. Global Liquid Biopsy Oncology Market & Forecast - by Clinical Application (2015 - 2026)
7.1 Global Liquid Biopsy Oncology Application - Therapy Selection Market & Forecast
7.2 Global Liquid Biopsy Oncology Application - Treatment Monitoring Market & Forecast
7.3 Global Liquid Biopsy Oncology Application - Early Cancer Screening Market & Forecast
7.4 Global Liquid Biopsy Oncology Application - Recurrence Monitoring Market & Forecast

8. Global Liquid Biopsy Market & Forecast - by End User (2015 - 2026)
8.1 Global Liquid Biopsy - Reference Laboratories Market & Forecast
8.2 Global Liquid Biopsy - Hospitals and Physician Laboratories Market & Forecast
8.3 Global Liquid Biopsy - Academic and Research Centers Market & Forecast
8.4 Global Liquid Biopsy - Other End Users Market & Forecast

9. Global Liquid Biopsy Market & Forecast - by Sample Type (2015 - 2026)
9.1 Global Liquid Biopsy - Blood Sample Market & Forecast
9.2 Global Liquid Biopsy - Urine Sample Market & Forecast
9.3 Global Liquid Biopsy - Other Fluids Sample Market & Forecast

10. Liquid Biopsy Market & Forecast - Regional Analysis (2015 - 2026)
10.1 North America Liquid Biopsy Market & Forecast
10.2 Asia Pacific Liquid Biopsy Market & Forecast
10.3 Europe Liquid Biopsy Market & Forecast
10.4 Latin America Liquid Biopsy Market & Forecast
10.5 Middle East & Africa Liquid Biopsy Market & Forecast

11. Liquid Biopsy Market Share & Forecast - Geographical Analysis (2015 - 2026)
11.1 North America Liquid Biopsy Market & Forecast
11.2 Asia Pacific Liquid Biopsy Market & Forecast
11.3 Europe Liquid Biopsy Market & Forecast
11.4 Middle East & Africa Liquid Biopsy Market & Forecast

12. Liquid Biopsy Initiatives

13. Liquid Biopsy Companies Financing Details

14. Company Profiles

• ANGLE plc
• Bio-Rad Laboratories Inc
• Biocept Inc.
• Clearbridge BioMedics Pte Ltd
• Cynvenio Biosystems Inc.
• Exosome Diagnostics Inc
• Foundation Medicine Inc
• Genomic Health
• GRAIL
• Guardant Health Inc.
• MDxHealth
• Menarini-Silicon Biosystems
• Myriad Genetics Inc
• Pathway Genomics
• Personal Genome Diagnostics
• QIAGEN NV
• RainDance Technologies (Acquired by Bio-Rad Laboratories Inc.)
• Roche Diagnostics (A Subsidiary of F. Hoffmann-La Roche AG)
• Thermo Fisher Scientific Inc
• Trovagene Inc

For more information about this company profile visit https://www.researchandmarkets.com/research/msk9sx/global_6_5?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com